Hyster-Yale (HY) EBIT (2011 - 2026)

Hyster-Yale (HY) has reported EBIT for 16 consecutive years, with -$18.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBIT fell 116.47% year-over-year to -$18.4 million; the trailing twelve-month figure through Jun 2026 stood at -$81.3 million (down 203.96% YoY), and the FY2025 full-year result was -$22.1 million, down 109.03% from the prior year.
• EBIT improved to -$18.4 million in Q2 2026 per HY's latest filing, from -$28.0 million in the prior quarter.
• Across five years, EBIT topped out at $95.6 million in Q2 2024 and bottomed at -$37.2 million in Q4 2025.
• Historically, EBIT has averaged $19.2 million across 5 years, with a median of $20.6 million in 2022.
• The sharpest annual moves came in 2022 and 2023: EBIT tumbled 690.32% in 2022, then soared 474.52% in 2023.
• Over 5 years, EBIT stood at $19.8 million in 2022, then surged by 145.96% to $48.7 million in 2023, then sank by 33.68% to $32.3 million in 2024, then slumped by 215.17% to -$37.2 million in 2025, then surged by 50.54% to -$18.4 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$18.4 million, -$28.0 million, and -$37.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.